Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-06-29

FDA Approved: NALOXONE HYDROCHLORIDE — Original Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved an original application for a generic naloxone hydrochloride product by Mylan Institutional LLC (ANDA 205014) to treat opioid overdose by reversing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone Hydrochloride (Naloxone hydrochloride)

Snippet

ORIG AP for NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE)